Development of an integrated 4EU+ pharmacoepidemiology and pharmacovigilance educational programme (DETERMINANT)

Leading university:		Sorbonne University
Project leader:		Assoc. Prof. Julien Kirchgesner
Contact:
Flagship:		Flagship 1: Urban Health and Demographic Change
Participating universities:		Charles University, Heidelberg University, University of Copenhagen, University of Milan

The DETERMINANT project aims to ensure the long-term sustainability of the 4EU+PharmacoEpi programme by establishing a Joint Master's Program in pharmacoepidemiology and pharmacovigilance involving all universities within the 4EU+ Alliance. This objective will be accomplished through four work packages:

• WP1: Conducting a comprehensive assessment of the existing courses in pharmacoepidemiology and pharmacovigilance offered by each university within the 4EU+ Alliance.

• WP2: Establishing collaborations with Associated partners of the 4EU+ Alliance to enhance the programme's scope and resources.

• WP3: Developing a framework for a Joint Master's Degree that incorporates all universities within the 4EU+ Alliance.

• WP4: Submitting an application to the Erasmus Mundus Joint Master’s programme in either 2025 or 2026, with support from an application to the Erasmus Mundus Design Measures call in February 2024.